Therapy News and Research

RSS
Alternative treatment for autism focuses on controlling the 'fight or flight' response

Alternative treatment for autism focuses on controlling the 'fight or flight' response

Researcher receives $225,000 grant to study epigenetic changes associated with chemotherapy

Researcher receives $225,000 grant to study epigenetic changes associated with chemotherapy

Principal investigators at Nationwide Children's Hospital elected as AAAS Fellows

Principal investigators at Nationwide Children's Hospital elected as AAAS Fellows

Occupational therapy can benefit children with autism

Occupational therapy can benefit children with autism

AATS, cardiovascular professional societies release overview of transcatheter therapies for mitral regurgitation

AATS, cardiovascular professional societies release overview of transcatheter therapies for mitral regurgitation

Icahn School of Medicine receives $2.7M to investigate narrow pathway targeted immune therapy

Icahn School of Medicine receives $2.7M to investigate narrow pathway targeted immune therapy

EMA grants accelerated assessment to Boehringer Ingelheim's Faldaprevir compound

EMA grants accelerated assessment to Boehringer Ingelheim's Faldaprevir compound

SillaJen executes definitive merger agreement to acquire Jennerex

SillaJen executes definitive merger agreement to acquire Jennerex

Oxytocin maintains bond between loving couples, promotes monogamy

Oxytocin maintains bond between loving couples, promotes monogamy

Expert offers tips for families to avoid sensory processing disorders during holiday travels

Expert offers tips for families to avoid sensory processing disorders during holiday travels

Sacral neuromodulation stands test of time in LUTD

Sacral neuromodulation stands test of time in LUTD

First symptom predicts urodynamic diagnosis in MUI

First symptom predicts urodynamic diagnosis in MUI

New diabetes has little impact on outcomes in elderly hypertensives

New diabetes has little impact on outcomes in elderly hypertensives

Anti-epileptic drugs, bone loss and supplements

Anti-epileptic drugs, bone loss and supplements

DSMB reviews safety data from Phase I/IIa clinical trial of NTCELL for Parkinson’s disease

DSMB reviews safety data from Phase I/IIa clinical trial of NTCELL for Parkinson’s disease

Radiation therapy now available via latest version of ACR ppropriateness Criteria

Radiation therapy now available via latest version of ACR ppropriateness Criteria

CRISPR-Cas-system: A promising tool for genetic engineering

CRISPR-Cas-system: A promising tool for genetic engineering

New study led by CDC reports nearly half of US children are diagnosed with ADHD

New study led by CDC reports nearly half of US children are diagnosed with ADHD

Super cocktail of six natural compounds killed 100% of breast cancer cells without toxic side effects

Super cocktail of six natural compounds killed 100% of breast cancer cells without toxic side effects

UCSF investigator receives $89 M grant to research on anal cancer in people with HIV

UCSF investigator receives $89 M grant to research on anal cancer in people with HIV

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.